How much does enzalutamide (enzalutamide) cost in China?
Enzalutamide (Enzalutamide) is a drug used to treat cancer, primarily prostate cancer. It belongs to a class of drugs called nonsteroidal antiandrogens, commonly known as antiandrogen receptor (AR) inhibitors.
Enzalutamide (enzalutamide) is now on the market in China and has been included in the scope of medical insurance. Patients can purchase it directly in China at a price of approximately four to five thousand yuan. For specific price information and detailed policies on medical insurance reimbursement, patients are advised to consult the pharmacy of their local hospital for accurate information. Abroad, the prices of generic drugs of enzalutamide are more affordable, especially those in India, which cost about more than 2,000 yuan, only about half of the domestic price. It is worth mentioning that the ingredients of these generic drugs are basically the same as those of the original drugs.

Prostate cancer is one of the common malignant tumors in men. Malignant tumors usually form in prostate tissue. Androgens are important hormones that promote the growth of prostate cancer. The mechanism of action of enzalutamide (enzalutamide) is to slow down or stop the growth of cancer cells by inhibiting the binding of androgens and blocking the stimulating effect of androgens on the growth of cancer cells.
Enzalutamide is commonly used to treat advanced prostate cancer, especially in patients who have already received chemotherapy or hormone therapy and have developed recurrence or metastasis. It is usually taken as an oral medication once daily and can be used alone or in combination with other treatments such as surgery or radiation therapy.
Clinical trials have shown that enzalutamide can significantly extend patients’ survival and improve their quality of life. It has shown good efficacy in improving symptoms, reducing pain, and slowing disease progression. However, like other drugs, enzalutamide may also cause some side effects, including fatigue, high blood pressure, dizziness, abnormal liver function, etc., so the patient's condition and adverse reactions need to be closely monitored during use.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)